VLDLR disturbs quiescence of breast cancer stem cells in a ligand-independent function

Breast cancer stem cells are responsible for cancer initiation, progression, and drug resistance. However, effective targeting strategies against the cell subpopulation are still limited. Here, we unveil two splice variants of very-low-density lipoprotein receptor, VLDLR-I and -II, which are highly...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Mengying, Zhan, Yajing, Hou, Zhijie, Wang, Chunli, Fan, Wenjun, Guo, Tao, Li, Zhuoshi, Fang, Lei, Lv, Shasha, Li, Sisi, Gu, Chundong, Ye, Mingliang, Qin, Hongqiang, Liu, Quentin, Cui, Xiaonan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767959/
https://www.ncbi.nlm.nih.gov/pubmed/36568166
http://dx.doi.org/10.3389/fonc.2022.887035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767959/
https://www.ncbi.nlm.nih.gov/pubmed/36568166
http://dx.doi.org/10.3389/fonc.2022.887035

Ejemplares similares